For Immediate Release

November 1, 2013

Sumitomo Chemical Reports
Consolidated Financial Results
For the Half-Year Ended September 30, 2013
The Sumitomo Chemical Group’s sales for the half-year ended September 30, 2013 were
¥1,050.8 billion, an increase of ¥89.4 billion compared with the same period of the previous
fiscal year. The Group recorded operating income of ¥46.3 billion, ordinary income of ¥44.3
billion and net income of ¥12.5 billion, all showing year-on-year increases.

Sumitomo Chemical decided to pay an interim dividend of ¥6 per share.

The Sumitomo Chemical Group’s financial results by business segment for the half-year
were as follows.

Basic Chemicals
Market prices remained low for methyl methacrylate and raw materials for synthetic fibers,
and shipments of these products also remained low. Shipments of aluminum decreased.
On the other hand, the correction of the yen’s appreciation had a positive effect on sales
from overseas subsidiaries in yen terms. As a result, the segment’s sales increased by ¥4.1
billion from the same period of the previous fiscal year, to ¥136.9 billion, and operating
income decreased by ¥2.2 billion, to a loss of ¥4.8 billion.

Petrochemicals & Plastics
Market prices for synthetic resins and petrochemical products rose due to higher
feedstock prices, but shipments from overseas subsidiaries declined on account ofmaintenance work at Petro Rabigh. The correction of the yen’s appreciation had a positiveeffect on sales from overseas subsidiaries in yen terms. As a result, the segment’s sales
increased by ¥25.7 billion from the same period of the previous fiscal year, to ¥368.9 billion,and operating income improved by ¥4.1 billion, to ¥3.9 billion.

IT-related Chemicals
Sales of polarizing film used in liquid crystal displays (LCDs) increased due to growth indemand. Sales rose as a newly-built touchscreen panel facility in South Korea began
full-fledged operations in the third quarter of the previous year. As a result, including thepositive effect of the correction of the yen’s appreciation, the segment’s sales increased by¥37.7 billion compared with the same period of the previous fiscal year, to ¥181.8 billion,and operating income grew by ¥19.3 billion, to ¥21.7 billion.

Health & Crop Sciences
In the area of crop protection chemicals, shipments of herbicides and other products rosein overseas markets due to increased production capacity and expanded sales. Market
prices of the feed additive methionine declined. The correction of the yen’s appreciation
had a positive effect on sales from overseas subsidiaries in yen terms. As a result, thesegment’s sales increased by ¥19.7 billion compared with the same period of the previous
fiscal year, to ¥139.5 billion, and operating income grew by ¥ 3.8 billion, to ¥11.6 billion.

Pharmaceuticals
In Japan, in addition to sales of Aimix® (anti-hypertension drug) that was launched in
December last year, sales of Metgluco® (biguanide oral hypoglycemic) and Lonasen®
(atypical antipsychotic) increased, but overall sales decreased as a result of a significant
decline in shipments of other existing products. In North America, shipments of Xopenex®
(short-acting beta-agonist) fell sharply as marketing exclusivity ended, but shipments ofLatuda® (atypical antipsychotic) continued to rise. The correction of the yen’s appreciation
had a positive effect on sales from overseas subsidiaries in yen terms. As a result, thesegment’s sales increased by ¥3.0 billion compared with the same period of the previous
fiscal year, to ¥197.2 billion, and operating income decreased by ¥2.5 billion, to ¥20.6billion.

OthersIn addition to the above five segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering, andconstruction management of chemical plants, providing transport and warehousing, andconducting materials and environmental analysis. The segment’s sales declined by ¥0.8billion compared with the same period of the previous fiscal year, to ¥26.4 billion, andoperating income decreased by ¥0.8 billion, to ¥3.4 billion.

The Company has revised its consolidated financial forecast for fiscal 2013, announced on
May 15, 2013, as follows.
Revisions to Consolidated Financial Forecast for the Full-Year Ending March 31, 2014
(Millions of yen)
Operating
Ordinary
Earnings Per
Sales
Net Income
Share (yen)IncomeIncomePrevious Forecast (A)2,350,000

90,00090,00030,000

18.35

Revised Forecast (B)2,230,000

105,000

100,000

30,00018.35

Variance in Amount (B-A)-120,000

15,00010,000

--5.1

16.7

11.1

-1,952,492

45,01650,252-51,076

Variance in Percentage (%)
Results for Full-Year ended
March 31, 2013-31.25

Sales are expected to be lower than previously projected chiefly due to lower shipments ofproducts in the Petrochemicals & Plastics and Basic Chemicals segments. Operating
income and ordinary income, however, are expected to exceed the previous forecast
mainly because of an increase in shipments of products in the Pharmaceuticals, IT-related
Chemicals and Health & Crop Sciences segments. The new forecast is based on theassumptions of a foreign exchange rate of ¥95/US$ and a naphtha price of ¥65,000/kl forthe second half of the current fiscal year.

Cautionary Statement
Statements made in this release with respect to Sumitomo Chemical’s current plans,estimates, strategies and beliefs that are not historical facts are forward-looking
statements about the future performance of Sumitomo Chemical. These statements arebased on management’s assumptions and beliefs in light of the information currently
available to it, and involve risks and uncertainties.
The important factors that could cause actual results to differ materially from those
discussed in the forward-looking statements include, but are not limited to, general
economic conditions in Sumitomo Chemical’s markets; demand for, and competitive
pricing pressure on, Sumitomo Chemical’s products in the marketplace; Sumitomo
Chemical’s ability to continue to win acceptance for its products in these highly
competitive markets; and movements of currency exchange rates.

Summary of Consolidated Results(1) Results of Operations:

Net sales
Operating income
Ordinary income
Income before income taxesand minority interests
Net income (loss)

Net income (loss) per 1,000 shares
Dividends per 1,000 shares:
Interim dividends

Comprehensive income(2) Financial Position:
Total assets
Total net asset(3) Cash Flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period(4) Results of Operations byBusiness Segment:
Net sales
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersOperating income (loss)
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersAdjustments

6 Months ended
September 30，2013
USD (Thousands)*(Millions)
1,050,806
10,749,934
46,332473,985
44,250452,685

6 Months ended
September 30，2012
Yen (Millions)961,383
24,481
18,94838,256
12,452

391,366
127,386

13,634(13,114)

Yen
7,618

USD*
78

Yen(8,023)

6,000

61

6,000

Yen
75,665

USD (Thousands)*
774,066

Yen (Millions)(11,511)

As of September 30, 2013
(Millions)
USD (Thousands)*
2,637,843
26,985,606
851,554
8,711,550

As of March 31, 2013
Yen (Millions)
2,472,091
747,482

6 Months ended
September 30，2013(Millions)
USD (Thousands)*
100,840
1,031,611(79,988)(818,292)(4,622)(47,284)
143,158
1,464,532

6 Months ended
September 30，2012
Yen (Millions)
61,837(104,821)
26,143
131,797

6 Months ended
September 30，2013(Millions)
USD (Thousands)*

6 Months ended
September 30，2012
Yen (Millions)

136,932
368,914
181,792
139,502
197,231
26,435
1,050,806

1,400,839
3,774,056
1,859,765
1,427,130
2,017,708
270,436
10,749,934

132,855
343,186
144,043
119,786
194,272
27,241
961,383(4,796)
3,855
21,705
11,574
20,6303,416(10,052)
46,332(49,064)
39,437222,046
118,404
211,049
34,946(102,833)
473,985(2,586)
(218)
2,402
7,728
23,1294,195(10,169)
24,481(Note)*:U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥97.75= $1 prevailing on September 30, 2013.